CEL-SCI CORPORATION

Company Information
Address 8229 BOONE BLVD STE 802
VIENNA, VA, 22182-2634

http://www.cel-sci.com

Information

DUNS: 102560141

# of Employees: 44


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Preclinical studies of PG70 LEAPS peptide vaccines for rheumatoid arthritis

    Amount: $806,505.00

    Currently FDA licensed pharmaceuticals used to treat rheumatoid arthritis RA focus largely on alleviation of symptoms either through pain management general immunosuppression or by antagonizing ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. Preclinical Studies of PG70 LEAPS Peptide Vaccines for Rheumatoid Arthritis

    Amount: $224,999.00

    DESCRIPTION (provided by applicant): Currently, FDA-licensed pharmaceuticals used to treat rheumatoid arthritis (RA) focus largely on alleviation of symptoms, either through pain management, general i ...

    SBIRPhase I2014Department of Health and Human Services
  3. Augmenting innate and vaccine immune response with der-G

    Amount: $104,091.00

    DESCRIPTION (provided by applicant): Concerns regarding the United States' vulnerability to a terrorist attack with smallpox have stimulated development of new vaccines, prophylactics and therapeutics ...

    SBIRPhase I2003Department of Health and Human Services
  4. derG Immunostimulant Prevention/Treatment of HSV Disease

    Amount: $162,132.00

    DESCRIPTION (provided by the applicant): The goal of this program is to develop derG as a therapeutic and/or prophylactic agent for HSV infections. DerG is a small peptide shown in preliminary experi ...

    SBIRPhase I2003Department of Health and Human Services
  5. Peptide Vaccine for Experimental Autoimmune Myocarditis

    Amount: $134,469.00

    DESCRIPTION (provided by the applicant): In A/J Mice Experimental Autoimmune Myocarditis (EAM) can be induced by infection with coxsackie virus B 3 or by immunization with murine or porcine cardiac m ...

    SBIRPhase I2003Department of Health and Human Services
  6. N/A

    Amount: $0.00

    N/A

    SBIRPhase I2000Department of Health and Human Services
  7. N/A

    Amount: $379,053.00

    N/A

    SBIRPhase II2000Department of Health and Human Services
  8. HETEROCONJUGATE VACCINES AGAINST HERPES SIMPLEX VIRUS

    Amount: $100,000.00

    N/A

    SBIRPhase I1998Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government